Pages

Thursday, April 28, 2011

Diabetes


Diabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes.
These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude more extensive evaluation and management of the patient by other specialists as needed.  
The recommendations included are diagnostic and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system (Table 1), developed by the American Diabetes Association (ADA) and modeled after existing methods, was utilized to clarify and codify the evidence that forms the basis for the recommendations.
The level of evidence that supports each recommendation is listed after each recommendation using the letters A, B, C, or E.

I. Classification and Diagnosis
A. Classification
In 1997, the ADA issued new diagnostic and classification criteria; in 2003, modifications were made regarding the diagnosis of impaired fasting glucose (IFG). The classification of diabetes includes four clinical classes:
  • Type 1 diabetes (results from ß-cell destruction, usually leading to absolute insulin deficiency).
  • Type 2 diabetes (results from a progressive insulin secretory defect on the background of insulin resistance).
  • Other specific types of diabetes due to other causes, e.g., genetic defects in ß-cell function, genetic defects in insulin action, diseases of the exocrine pancreas (such as cystic fibrosis), and drug or chemical induced (such as in the treatment of AIDS or after organ transplantation).
  • Gestational diabetes mellitus (GDM) (diagnosed during pregnancy).

http://www.mededsys.com/product_info.php?cPath=1&products_id=48

Wednesday, April 27, 2011

Lung Cancer


Lung Cancer

Lung cancer is the leading cause of cancer deaths. Because of a lack of adequate detection methods, malignancies are often diagnosed at an advanced stage. While the five-year survival rate among patients with stage I lung cancer is about 70 percent, it is only 5 percent among those with stage IV disease. Unfortunately, stage I diagnoses are rare.

In 1993, the Early Lung Cancer Action Project (ELCAP) found that, with annual screening with spiral computed tomography (CT), more than 80 percent of persons diagnosed with lung cancer had stage I disease. What investigators didn't know, however, was whether early intervention was effective enough to justify screening large numbers of asymptomatic people at risk for lung cancer. 

Late in October, 2006, researchers in New York announced a finding that could very well change the entire landscape of lung cancer diagnosis and treatment. The new research shows that annual screening using computed tomography (CT) detected lung tumors at their earliest stage in 85 percent of patients.  This news out of NewYork-Presbyterian/Weill Cornell hospital and published in The New England Journal of Medicine led to an expected flurry of media reports, calling the issue of lung cancer and detection methods to the full attention of the American public and medical community. We present a few of those media reports here for your review:

Study Sees Gain on Lung Cancer


New York Times, October 26, 2006 By GINA KOLATA
Researchers in New York report that millions of lives could be saved by detecting lung cancer early with annual CT scans and treating it immediately, when it can still be cured.
The stakes are high: while death rates for other cancers have fallen, lung cancer is the leading cause of cancer deaths in this country, killing more than 160,000 people a year.

Spirometry

SPIROMETRY

Spirometry with flow volume loops assesses the mechanical properties of the respiratory system by measuring expiratory volumes and flow rates. This test requires the patient to make a maximal inspiratory and expiratory effort. The patient in a sitting position breathes into a mouthpiece, and nose clips are placed to prevent air leak. To obtain interpretable results from spirometry, it is essential that the patient give full effort during testing. At least three tests of acceptable effort are performed to ensure reproducibility of results.

Flow volume loops provide a graphic illustration of a patient's spirometric efforts. Flow is plotted against volume to display a continuous loop from inspiration to expiration. The overall shape of the flow volume loop is important in interpreting spirometric results. The volume versus time curve is an alternative way of plotting spirometric results and is another useful illustration of patient performance.
Spirometry is a versatile test of pulmonary physiology. Reversibility of airways obstruction can be assessed with the use of bronchodilators. After spirometry is completed, the patient is given an inhaled bronchodilator and the test is repeated. The purpose of this is to assess whether a patient's pulmonary process is bronchodilator responsive by looking for improvement in the expired volumes and flow rates. In general, a > 12% increase in the FEV1 (an absolute improvement in FEV1 of at least 200 ml) or the FVC after inhaling a beta agonist is considered a significant response. However, the lack of an acute bronchodilator effect during spirometry does not exclude a response to long-term therapy.
Similarly, spirometry can be used to detect the bronchial hyperreactivity that characterizes asthma. By inhaling increasing concentrations of histamine or methacholine, patients with asthma will demonstrate symptoms and produce spirometric results consistent with airways obstruction at much lower threshold concentration than normals.
Definitions and Terms
  • FEV1 - forced expiratory volume 1 - the volume of air that is forcefully exhaled in one second.
  • FVC - forced vital capacity - the volume of air that can be maximally forcefully exhaled
  • FEV1/FVC - ratio of FEV1 to FVC, expressed as a percentage
  • FEF25 - 75 - forced expiratory flow - the average forced expiratory flow during the mid (25 - 75%) portion of the FVC
  • PEF - peak expiratory flow rate - the peak flow rate during expiration
Spirometry is typically reported in both absolute values and as a predicted percentage of normal. Normal values vary depending on gender, race, age, and height. It is therefore not possible to interpret PFT's without such information. There is no single set of standard reference values, however, and "normal" varies with the reference value used in each laboratory. It is therefore important to ensure that the reference formulas in a PFT lab are applicable to the patient population being tested.

REQUIREMENTS FOR GOOD PFT’s
Obtaining useful information from pulmonary function tests requires both adequate equipment and reproducible performance. If these requirements are not met, the results must be interpreted with caution.

The American Thoracic Society (ATS) has published guidelines for the standardization of spirometry equipment and performance. Spirometric equipment should be selected to meet ATS recommendations, and at least daily monitoring and calibration must be done to obtain consistent and accurate PFT's.
Many physicians, however, are not involved in the selection of the equipment used for testing or its maintenance. But because spirometry is such an effort dependent test, they should examine each spirogram using performance criteria as set forth by the ATS. These include criteria for acceptability and reproducibility.
http://www.mededsys.com/product_info.php?cPath=2_29&products_id=87

Tuesday, April 26, 2011

Mededsys

 

  Medical Education Systems, Inc. is dedicated to helping you meet your continuing education and professional goals. Our mission is to provide healthcare professionals innovative training for relicensure, self-improvement and career advancement. We provide you with the highest quality, state-of-the-art, non-traditional programs available anywhere. We have one of the largest selections of continuing education courses you will find anywhere on the Internet today. Our online courses are available 24/7, giving you the chance to take needed courses anytime, anywhere. Visit our web site, http://www.mededsys.com/, and see our selection of courses for yourself!

Ranging from courses for EMTs to neo-natal care and treating pain, our curriculum will satisfy your intellectual curiosity and your state’s requirements. Easy access, quick results and printed certificates of completion all combine to make us the logical choice when you go hunting for CEU’s. Medical Education Systems, Inc. provides home study courses and contact hours (CEU's) for EMTs, Nurses, Respiratory Therapists, Sleep Therapists, and other healthcare professionals. We understand that every profession has different requirements for contact hours as set forth by your professional society and your state board requirements. For a comprehensive understanding of how our courses and continuing education program fit in with these requirements, please view our Accreditation page. (Always check your board for specific requirements).

Medical Education Systems, Inc. is an approved provider of continuing nursing education by the Alabama Board of Nursing, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation ABNP1399.

This program has been designed to meet the Minnesota Board of Nursing continuing education requirements, and is approved by the California Board of Registered Nursing (CEP #10661) and approved by the Florida Board of Nursing (CEP #50-7376).

Our courses are also Accepted for Nursing in:
AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VI, VT, WA, WI, WV, WY, All Military.

Don’t wait, come see us and get started on courses you need right now!!

Treatin an Accute Asthma Attack in the Hospital

Acute Asthma Treatment

http://www.mededsys.com/index.php

Treating an Acute Attack in the Hospital. An acute attack may require hospitalization. Laboratory tests, an electrocardiogram (ECG), and a chest x-ray are performed to determine lung function, oxygen levels, and other indications of severity or rule out other causes. Depending on the results, the following treatments may be given:
*       Beta2-agonists are the standard therapy. They may be administered with a nebulizer (a device that administers the drug in a fine spray) or given hourly with an inhaler. Studies are suggesting the use of inhaler is equally or possibly more effective than a nebulizer. Intravenous delivery is not recommended in most cases.
*      
*       A corticosteroid (commonly called a steroid) given within the first hour helps reduce the need for hospitalization. Steroids are typically administered intravenously or as an injection in adults. Lower doses work as well as higher ones in these situations. Intravenous magnesium opens airways and is an important emergency treatment for patients with very severe asthma.
*      
*       Oxygen is usually administered, and can be life saving in severe cases.
*       In life-threatening situations, the patient may require mechanical ventilation.
*       Antibiotics are not useful for asthma attacks if there is no strong evidence of the presence of a bacterial infection. (Viral infections, most often colds and flus, are more likely to trigger an asthma attack. In such cases, antibiotics do not appear to be beneficial and may have adverse effects.)

Monday, April 25, 2011

The Next Hospital Crisis

While hospitals in the United States are already scrambling to control the impact hospital-based MRSA and its “partner” Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA), they of may well be poised on the brink of the next drug-resistant infection epidemic, with outbreaks of Acinetobacter baumannii already appearing in hospitals here, according to experts speaking at the 2006 annual Interscience Conference on Antimicrobial Agents and Chemotherapy.

The spread of the bacteria has already reached epidemic proportions in Israeli and Latin American hospitals, and poses a serious problem in Europe as well. In fact, “Acinetobacter has been designated as the gram-negative MRSA [methicillin-resistant Staphylococcus aureus],” said Dr. Harald Seifert, a professor at the University of Cologne's Institute of Medical Microbiology and Hygiene.

We are not only dealing with an increasing incidence of multiresistant Acinetobacter, but we seem to be dealing with an increasing absolute incidence of Acinetobacter,” said Dr. Anthony D. Harris, an epidemiologist for the University of Maryland Medical System, Baltimore.

Acinetobacter baumannii is a nonmotile, gram-negative bacterium that affects mainly immunocompromised patients, particularly patients in the ICU setting or those who have been hospitalized for long periods, Dr. Seifert said at the meeting sponsored by the American Society for Microbiology. Though the organism can cause a wide range of infections, the most common are respiratory tract, bloodstream, urinary tract, skin and soft tissue, and wound infections. http://www.mededsys.com/product_info.php?cPath=1&products_id=69

Wednesday, April 20, 2011

Lung Cancer

http:www.mededsys.com/
Introduction
Lung cancer is the leading cause of cancer deaths. Because of a lack of adequate detection methods, malignancies are often diagnosed at an advanced stage. While the five-year survival rate among patients with stage I lung cancer is about 70 percent, it is only 5 percent among those with stage IV disease. Unfortunately, stage I diagnoses are rare.

In 1993, the Early Lung Cancer Action Project (ELCAP) found that, with annual screening with spiral computed tomography (CT), more than 80 percent of persons diagnosed with lung cancer had stage I disease. What investigators didn't know, however, was whether early intervention was effective enough to justify screening large numbers of asymptomatic people at risk for lung cancer.

Late in October, 2006, researchers in New York announced a finding that could very well change the entire landscape of lung cancer diagnosis and treatment. The new research shows that annual screening using computed tomography (CT) detected lung tumors at their earliest stage in 85 percent of patients.  This news out of NewYork-Presbyterian/Weill Cornell hospital and published in The New England Journal of Medicine led to an expected flurry of media reports, calling the issue of lung cancer and detection methods to the full attention of the American public and medical community. We present a few of those media reports here for your review:

Tuesday, April 19, 2011

HIV-AIDS


Nearly 25 years after the first report of a handful of cases of a nameless deadly disease among gay men in New York and Los Angeles, there are still over 1 million persons living with HIV in the United States. About one-fourth of those with HIV have not yet been diagnosed and are unaware of their infection. The “new” syndrome discovered 25 years ago has become one of the deadliest epidemics in human history, killing more than 25 million people around the world, including more than 500,000 Americans.
In the last decade, major advances in prevention and treatment for HIV/AIDS have prolonged and improved the lives of many, but despite extremely beneficial advances, the epidemic is far from over. An estimated 40,000 Americans still become infected with HIV every year, and many of these are young persons under the age of 25. African American men and women are among the hardest hit populations in the U.S.  In 2004, they accounted for half of all new HIV diagnoses in this country and more than a third of AIDS deaths to date. African American men who have sex with men (MSM) are especially hard hit.  Recent data show significant declines in HIV diagnoses in nearly every group of African Americans except black MSM. Women also remain a particularly vulnerable population, accounting for 29% of all HIV diagnoses in 2004.  The inescapable truth is that, to defeat HIV and AIDS, we need to reduce the number of people who become infected in the first place. Twenty-five years since the onset of the epidemic, prevention is still the only “cure” we have for HIV/AIDS. A comprehensive approach must be used to prevent the further spread of HIV and AIDS. Comprehensive HIV prevention strategies include monitoring the epidemic to target prevention and care activities, researching the effectiveness of prevention methods, diffusing proven effective interventions, funding the implementation and evaluation of prevention efforts in high-risk communities, encouraging early diagnosis of HIV infection, and fostering linkages between prevention and treatment programs. Many governmental and non-governmental organizations at all levels collaborate to implement, evaluate, disseminate, and further develop and strengthen effective HIV prevention efforts nationwide http://www.mededsys.com/product_info.php?cPath=1&products_id=70

Friday, April 15, 2011

Medical Errors

http:www.mededsys.com/

Medical Errors

Most Americans have grown up having the utmost respect for the medical profession and what it has accomplished over the decades. The family doctor who could fix anything became a fixture in our society. If “doc” said you needed something, then that is what you got. People not only didn’t worry about the their healthcare, they didn’t think about it!  The physician became almost “infallible” in his or her opinions or actions. It was almost like the situation seen in the film “The Wizard of Oz.” What the Wizard ordered was to be done. The system seemed to work just fine. Then came along Dorothy and her darling doggie Toto.

During their visit to the Wizard’s place of wizardry, Toto’s curiosity drove him to pull back the curtain, revealing the Wizard as just an ordinary, albeit educated, man whose views and opinions were not always infallible. In the case of the medical profession, the pulling back of “the curtain” has not been such a rapid and shocking event. It has taken place over time.

To Error is Human: The Report


The exposing of flaws in our health care system began in the media. Sensational medical errors were splattered all over the popular media, and eventually healthcare organizations and government agencies began to investigate. The results of these investigations, as reported in the Executive Summary of an Institute of Medicine report entitled “To Err Is Human: Building a Safer Health System” (2000) proved to be just as shocking as Toto’s pulling back of the curtain:
“It was reported that the knowledgeable health reporter for the Boston Globe, Betsy Lehman, died from an overdose during chemotherapy. Willie King had the wrong leg amputated. Ben Kolb was eight years old when he died during ''minor" surgery due to a drug mix-up.
These horrific cases that make the headlines are just the tip of the iceberg. Two large studies, one conducted in Colorado and Utah and the other in New York, found that adverse events occurred in 2.9 and 3.7 percent of hospitalizations, respectively. In Colorado and Utah hospitals, 6.6 percent of adverse events led to death, as compared with 13.6 percent in New York hospitals. In both of these studies, over half of these adverse events resulted from medical errors and could have been prevented.
When extrapolated to the over 33.6 million admissions to U.S. hospitals in 1997, the results of the study in Colorado and Utah imply that at least 44,000 Americans die each year as a result of medical errors.3 The results of the New York Study suggest the number may be as high as 98,000. Even when using the lower estimate, deaths due to medical errors exceed the number attributable to the 8th-leading cause of death. More people die in a given year as a result of medical errors than from motor vehicle accidents (43,458), breast cancer (42,297), or AIDS (16,516).
Total national costs (lost income, lost household production, disability and health care costs) of preventable adverse events (medical errors resulting in injury) are estimated to be between $17 billion and $29 billion, of which health care costs represent over one-half.
In terms of lives lost, patient safety is as important an issue as worker safety. Every year, over 6,000 Americans die from workplace injuries. Medication errors alone, occurring either in or out of the hospital, are estimated to account for over 7,000 deaths annually.  http://www.mededsys.com/product_info.php?cPath=1&products_id=71

Thursday, April 14, 2011

Continuin Education Center-Ceus

Guillain-Barre Syndrome
Guillain-Barré syndrome is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of this disorder include varying degrees of weakness or tingling sensations in the legs. In many instances, the weakness and abnormal sensations spread to the arms and upper body. These symptoms can increase in intensity until the muscles cannot be used at all and the patient is almost totally paralyzed. In these cases, the disorder is life-threatening and is considered a medical emergency. The patient is often put on a respirator to assist with breathing. Most patients, however, recover from even the most severe cases of Guillain-Barré syndrome, although some continue to have some degree of weakness. Guillain-Barré syndrome is rare. Usually Guillain-Barré occurs a few days or weeks after the patient has had symptoms of a respiratory or gastrointestinal viral infection. Occasionally, surgery or vaccinations will trigger the syndrome. The disorder can develop over the course of hours or days, or it may take up to 3 to 4 weeks. No one yet knows why Guillain-Barré strikes some people and not others or what sets the disease in motion. What scientists do know is that the body's immune system begins to attack the body itself, causing what is known as an autoimmune disease. Guillain-Barré is called a syndrome rather than a disease because it is not clear that a specific disease-causing agent is involved. Reflexes such as knee jerks are usually lost. Because the signals traveling along the nerve are slower, a nerve conduction velocity (NCV) test can give a doctor clues to aid the diagnosis. The cerebrospinal fluid that bathes the spinal cord and brain contains more protein than usual, so a physician may decide to perform a spinal tap.
Guillain-Barré syndrome can affect anybody. It can strike at any age and both sexes are equally prone to the disorder. The syndrome is rare, however, afflicting only about one person in 100,000. Occasionally surgery or vaccinations will trigger the syndrome. http://www.mededsys.com/product_info.php?cPath=1&products_id=233

Tuesday, April 12, 2011

Continuing Education Center-Ceus

http:www.mededsys.com/
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
The condition known as COPD has been associated with considerable confusion and disagreement among health care professionals. Even defining the term has been somewhat controversial—much less determining how to diagnose and manage the condition. Given the relative confusion and disagreement among health care professionals regarding the topic of “COPD,” it was an historic breakthrough that on April 4, 2001, the medical world was greeted with the following important news release:


FOR IMMEDIATE RELEASE
Wednesday, April 4, 2001
Contact:   NHLBI Communications Office
                (301) 496-4236

International Guidelines Released on Chronic Obstructive Lung Disease (COPD)
Fourth Leading Cause of Death in US and Worldwide

The first international guidelines for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease (COPD) — currently the fourth leading cause of death in the US and worldwide — were released today by an international team of scientists from the Global Initiative for Chronic Obstructive Lung Disease (GOLD). The GOLD Workshop Report, which provides evidence-based recommendations for the clinical management of COPD, is the first step in an international effort to boost awareness of COPD and improve the way it is treated. GOLD was created by the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health and the World Health Organization.
According to NHLBI Director Dr. Claude Lenfant, "COPD has become a major public health problem worldwide. That's why we, with the WHO, initiated this program. We hope that this report will increase worldwide awareness of COPD and help the millions of people who suffer from this disease."
COPD, a term used to describe chronic bronchitis and emphysema, is a slowly progressive airways disease characterized by a gradual loss of lung function. In the US, it is caused primarily by cigarette smoking. There is no known cure, but smoking cessation can slow disease progression.
COPD has been on the increase in the US, and in 1996, an estimated 16 million Americans had COPD. The number of deaths attributed to COPD has also increased substantially in the past 40 years to approximately 100,000 men and women per year in the US alone. The highest rate of increase in deaths has been seen in white women.
It is expected that by 2020, COPD will rank as the third leading cause of death, surpassing stroke. The annual cost of COPD to the US economy is estimated at nearly $30.4 billion. http://www.mededsys.com/product_info.php?cPath=2_29&products_id=153&osCsid=m37bv6qngtnvgnb469su09iq92


Wednesday, April 6, 2011

Pain

http://www.mededsys.com/

Some facts you should know about pain and the scope of the problem in the United States:

  1.      90% of all diseases may be associated with pain
  2.       65 million Americans suffer painful disabilities at any given time
  3.      61% of medical directors of pain centers are anesthesiologists
  4.     It is estimated that of all pain practitioners, fewer than 10% are proficient in more than 8 out of 130+ diagnostic or therapeutic (treatment) procedures relative to pain
  5.        It is possible that an individual that is untrained and unskilled in the treatment or surgery that is being offered can legally treat you!
  6.    75% or more of patients in hospitals hurt and suffer more than they should.
  7.     Thirty-one million Americans have low back pain at any given time. One half of all working Americans admit to having back symptoms each year. One third of all Americans over age 18 had a back problem in the past five years severe enough for them to seek professional help. And the cost of this care is estimated to be a staggering $50 Billion yearly--and that's just for the more easily identified costs! (Data according to the American Chriropractic Association)
  8.       40 million visits to health care providers and prolong hospital stays are due to pain. (Last two items according to NIH)
http://www.mededsys.com/product_info.php?cPath=1&products_id=33